Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × Sodium Chloride × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 3 Glioblastoma 3 Colorectal Neoplasms 3 Skin Neoplasms 2 Ovarian Neoplasms 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Hot Flashes 2 Vulvodynia 1 Thromboembolism 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Hemorrhage 1 Pleural Effusion, Malignant 1 Platinum Resistant Ovarian Cancer 1 Parathyroid Neoplasms 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Neutropenia 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1

Interventions

blinatumomab 6 Tacrolimus 3 Rituximab 3 Cyclophosphamide 3 ponatinib 2 fludarabine 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 denileukin diftitox 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 Tomography, X-Ray Computed 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡